TITLE

Medgenics reports exercise of over-allotment option

PUB. DATE
March 2013
SOURCE
Medical Device Daily;3/27/2013, Vol. 17 Issue 59, p5
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
This article reports that Biopump technology developer Medgenics have announced that the underwriters of its public offering have exercised their option to purchase stocks and Series 2013-A warrants, allowing for the purchase of common stock at an initial exercise price of 6.48 U.S. dollars.
ACCESSION #
86441649

 

Related Articles

  • Financings Roundup.  // BioWorld Today;12/28/2010, Vol. 21 Issue 249, p6 

    The article reports that the underwriters of Anacor Pharmaceuticals Inc. have exercised their overallotment option and will purchase additional shares.

  • Financings Roundup.  // BioWorld Today;12/28/2010, Vol. 21 Issue 249, p7 

    The article reports that the underwriters of YM BioSciences Inc. have exercised their overallotment option and purchased additional shares.

  • FINANCINGS ROUNDUP.  // BioWorld Today;12/3/2009, Vol. 20 Issue 232, p8 

    The article reports that the overallotment option in a public offering of stock and warrants of Oncolytics Biotech Inc. has been exercised by underwriters.

  • ChipPac Raises $8.6M in Overallotment.  // Electronic News;02/18/2002, Vol. 48 Issue 8, p4 

    Reports on the funding raised by ChipPac Inc. Decision of the company to exercise its overallotment options; Sales of the common stock.

  • Financings Roundup.  // BioWorld Today;6/22/2011, Vol. 22 Issue 120, p3 

    The article reports on proceeds raised by Aveo Pharmaceuticals Inc. via an underwritten public offering and underwriters' exercise of an overallotment option.

  • Financings Roundup.  // BioWorld Today;12/27/2010, Vol. 21 Issue 248, p2 

    The article reports on the decision of Momenta Pharmaceuticals Inc. to exercise their overallotment option related to its recent public offering.

  • Untitled.  // BioWorld Today;10/7/2013, Vol. 24 Issue 192, p4 

    The article reports on a statement by Evote Pharma Inc. that underwriters exercised in full their overallotment option in the company's initial public offering (IPO).

  • Financings Roundup. Shaffer, Catherine // BioWorld Today;3/27/2013, Vol. 24 Issue 58, p4 

    The article reports that Medgenics Inc. of San Francisco, California said that underwriters exercised an option to purchase stock in its public offering in 2013.

  • Financings roundup.  // Medical Device Daily;12/14/2010, Vol. 14 Issue 241, p2 

    The article reports that underwriters of the secondary offering of Senior Housing Properties Trust have exercised their over-allotment option to purchase additional shares of beneficial interest.

  • Financings roundup.  // Medical Device Daily;6/15/2012, Vol. 16 Issue 114, p4 

    The article reports on the full exercise of the over-allotment option granted to the underwriters at a public offering of Trovagene, a developer of transrenal molecular diagnostics.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics